139 related articles for article (PubMed ID: 31410623)
1. To be capsulated or not be capsulated: that is the GAS question.
Creti R; Gherardi G; Imperi M
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2381-2383. PubMed ID: 31410623
[No Abstract] [Full Text] [Related]
2. Oxygen-dependent phenotypic variation in group A streptococcus.
Chiang-Ni C; Nian SY; Wu JJ; Chen CJ
J Microbiol Immunol Infect; 2016 Dec; 49(6):837-842. PubMed ID: 25649484
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Variation in the Group A
Sarkar P; Danger JL; Jain I; Meadows LA; Beam C; Medicielo J; Burgess C; Musser JM; Sumby P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333182
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the group A Streptococcal CovR response regulator causes dimerization and promoter-specific recruitment by RNA polymerase.
Gusa AA; Gao J; Stringer V; Churchward G; Scott JR
J Bacteriol; 2006 Jul; 188(13):4620-6. PubMed ID: 16788170
[TBL] [Abstract][Full Text] [Related]
5. Regulation of virulence factor expression in group A streptococcus.
Wessels MR
Trends Microbiol; 1999 Nov; 7(11):428-30. PubMed ID: 10542418
[No Abstract] [Full Text] [Related]
6. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hyaluronic acid capsule production by the has operon promoter in group A streptococci.
Alberti S; Wessels MR
Adv Exp Med Biol; 1997; 418():975-8. PubMed ID: 9331813
[No Abstract] [Full Text] [Related]
8. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus.
Cole JN; Pence MA; von Köckritz-Blickwede M; Hollands A; Gallo RL; Walker MJ; Nizet V
mBio; 2010 Aug; 1(4):. PubMed ID: 20827373
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.
Kwinn LA; Khosravi A; Aziz RK; Timmer AM; Doran KS; Kotb M; Nizet V
J Bacteriol; 2007 Feb; 189(4):1322-9. PubMed ID: 17114267
[TBL] [Abstract][Full Text] [Related]
10. Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos.
Schmidt KH; Günther E; Courtney HS
Med Microbiol Immunol; 1996 Feb; 184(4):169-73. PubMed ID: 8811648
[TBL] [Abstract][Full Text] [Related]
11. RivR is a negative regulator of virulence factor expression in group A Streptococcus.
Treviño J; Liu Z; Cao TN; Ramirez-Peña E; Sumby P
Infect Immun; 2013 Jan; 81(1):364-72. PubMed ID: 23147037
[TBL] [Abstract][Full Text] [Related]
12. Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis.
Flores AR; Jewell BE; Fittipaldi N; Beres SB; Musser JM
mBio; 2012 Nov; 3(6):e00413-12. PubMed ID: 23131832
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the group A streptococcal hyaluronic acid capsule operon.
van de Rijn I; Crater D; Dougherty B
Dev Biol Stand; 1995; 85():219-23. PubMed ID: 8586180
[No Abstract] [Full Text] [Related]
14. M-protein gene-type distribution and hyaluronic acid capsule in group A Streptococcus clinical isolates in Chile: association of emm gene markers with csrR alleles.
Wozniak A; Rojas P; Rodríguez C; Undabarrena A; Garate C; Riedel I; Román JC; Kalergis AM; García P
Epidemiol Infect; 2012 Jul; 140(7):1286-95. PubMed ID: 21906413
[TBL] [Abstract][Full Text] [Related]
15. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
[TBL] [Abstract][Full Text] [Related]
16. Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements.
Falaleeva M; Zurek OW; Watkins RL; Reed RW; Ali H; Sumby P; Voyich JM; Korotkova N
Infect Immun; 2014 Dec; 82(12):5293-307. PubMed ID: 25287924
[TBL] [Abstract][Full Text] [Related]
17. [Virulence factors in Streptococcus pyogenes infection].
Kawabata S
Nihon Saikingaku Zasshi; 2005 May; 60(2):365-74. PubMed ID: 15966363
[No Abstract] [Full Text] [Related]
18. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.
Heath A; DiRita VJ; Barg NL; Engleberg NC
Infect Immun; 1999 Oct; 67(10):5298-305. PubMed ID: 10496909
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and degradation of hyaluronic acid by bacteria of Streptococcus genus].
Beloded AV; Samoĭlenko II; Tsepilov RN
Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):83-90. PubMed ID: 21061584
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
